Entecavir and Jaundice cholestatic - a phase IV clinical study of FDA data

Summary:

Jaundice cholestatic is found among people who take Entecavir, especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Entecavir and have Jaundice cholestatic. It is created by eHealthMe based on reports of 5,769 people who have side effects when taking Entecavir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 03, 2022

5,769 people reported to have side effects when taking Entecavir.
Among them, 7 people (0.12%) have Jaundice cholestatic.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 5,782 Entecavir users for its effectiveness, alternative drugs and more.

What is Jaundice cholestatic?

Jaundice cholestatic is found to be associated with 1,504 drugs and 920 conditions by eHealthMe.

Number of Entecavir and Jaundice cholestatic reports submitted per year:

Could Entecavir cause Jaundice cholestatic?

Time on Entecavir when people have Jaundice cholestatic *:

Gender of people who have Jaundice cholestatic when taking Entecavir *:

female: 28.57 %
male: 71.43 %

Age of people who have Jaundice cholestatic when taking Entecavir *:

Common drugs people take besides Entecavir *:

Common side effects people have besides Jaundice cholestatic *:

Haematemesis (vomiting of blood): 3 people, 42.86%
Hepatocellular Carcinoma (liver cancer): 2 people, 28.57%
Therapeutic Embolisation: 2 people, 28.57%
Rectal Haemorrhage (bleeding from anus): 2 people, 28.57%
Pvt: 2 people, 28.57%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 2 people, 28.57%
Hepatic Vein Thrombosis (obstruction in the veins of the liver caused by a blood clot): 2 people, 28.57%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 2 people, 28.57%
Cholangitis Acute (rapid infection of bile duct): 2 people, 28.57%
Melaena (the passage of black, tarry stools): 2 people, 28.57%

Common conditions people have *:

Hepatitis B: 3 people, 42.86%
Stress And Anxiety: 2 people, 28.57%
High Blood Cholesterol: 2 people, 28.57%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 28.57%
Depression: 2 people, 28.57%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 2 people, 28.57%
Urinary Tract Disorder: 1 person, 14.29%
Type 1 Diabetes: 1 person, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 14.29%
High Blood Pressure: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and have Jaundice cholestatic?

Check whether Jaundice cholestatic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

Related studies

How severe was Jaundice cholestatic and when was it recovered:

Jaundice cholestatic in Entecavir

Expand to all the drugs that have ingredients of entecavir:

Jaundice cholestatic and drugs with ingredients of entecavir

Alternative drugs to, pros and cons of Entecavir:

Entecavir (5,782 reports)

Common Entecavir side effects:

Drug ineffective: 290 reports
Hepatitis b: 259 reports
Death: 229 reports
Thrombocytopenia (decrease of platelets in blood): 226 reports
Fatigue (feeling of tiredness): 196 reports
Weakness: 185 reports
Diarrhea: 184 reports
Fever: 179 reports

Browse all side effects of Entecavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Jaundice cholestatic treatments and more:

Jaundice cholestatic (4,754 reports)

COVID vaccines that are related to Jaundice cholestatic:

Common drugs associated with Jaundice cholestatic:

All the drugs that are associated with Jaundice cholestatic:

Jaundice cholestatic (1,504 drugs)

Common conditions associated with Jaundice cholestatic:

All the conditions that are associated with Jaundice cholestatic:

Jaundice cholestatic (920 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Entecavir) and Entecavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.